Inventor · disambiguated record
Andrew R. Chadeayne
Also filed as: CHADEAYNE ANDREW · CHADEAYNE ANDREW R
29 granted patents·40 pending applications·59 citations·filing 2006–2025
95Inventor score
Top patents by PatentIndex Score
69 records- 0197US12006290B2Crystalline norpsilocin compoundsCAAMTECH INC·Filed 2021·Granted Jun 11, 2024·3 cites·11 claims
- 0296US11819475B2Compositions comprising a serotonergic tryptamine compoundCAAMTECH INC·Filed 2021·Granted Nov 21, 2023·3 cites·18 claims
- 0396US11471439B2Compositions and methods comprising a combination of serotonergic drugsCAAMTECH INC·Filed 2021·Granted Oct 18, 2022·3 cites·22 claims
- 0496US11332441B2Crystalline N-methyl tryptamine derivativesCAAMTECH LLC·Filed 2020·Granted May 17, 2022·7 cites·18 claims
- 0596US10933073B2Compositions and methods comprising a psilocybin derivativeCAAMTECH LLC·Filed 2018·Granted Mar 2, 2021·27 cites·13 claims
- 0695US11926590B2Crystalline 4-hydroxy-N,N-di-n-propyltryptammonium (4-HO-DPT) saltsCAAMTECH INC·Filed 2021·Granted Mar 12, 2024·3 cites·5 claims
- 0795US11753375B2Crystalline psilacetin derivativesCAAMTECH INC·Filed 2021·Granted Sep 12, 2023·3 cites·18 claims
- 0894US11358934B2Crystalline forms of psilacetinCAAMTECH LLC·Filed 2020·Granted Jun 14, 2022·3 cites·11 claims
- 0993US11739060B2Crystalline 5-methoxy-n,n-diallyltryptamine compoundsCAAMTECH INC·Filed 2021·Granted Aug 29, 2023·2 cites·16 claims
- 1092US11974984B2Compositions and methods comprising a combination of serotonergic drugsCAAMTECH LLC·Filed 2020·Granted May 7, 2024·2 cites·12 claims
- 1188US11858896B2Crystalline dimethyl tryptamine analoguesCAAMTECH INC·Filed 2021·Granted Jan 2, 2024·1 cites·8 claims
- 1288US11780808B2Crystalline bis-miprocin fumarateCAAMTECH INC·Filed 2021·Granted Oct 10, 2023·1 cites·18 claims
- 1387US12187680B2Crystalline forms of psilacetinCAAMTECH INC·Filed 2023·Granted Jan 7, 2025·0 cites·4 claims
- 1486US2025154100A1Crystalline forms of psilacetinCAAMTECH INC·Filed 2024·Application pending·0 cites
- 1585US2024116868A1Dialkyl tryptamines and their therapeutic usesCAAMTECH INC·Filed 2023·Application pending·0 cites
- 1684US2024350455A1Compositions and methods comprising a combination of serotonergic drugsCAAMTECH INC·Filed 2024·Application pending·0 cites
- 1783US2025281458A1Dialkyl tryptamines and their therapeutic usesCAAMTECH INC·Filed 2025·Application pending·0 cites
- 1882US2023346747A1Dialkyl tryptamines and their therapeutic usesCAAMTECH INC·Filed 2023·Application pending·0 cites
- 1982US2023241027A1Dialkyl tryptamines and their therapeutic usesCAAMTECH INC·Filed 2023·Application pending·0 cites
- 2081US12383532B2Compositions and methods comprising a combination of serotonergic drugsCAAMTECH INC·Filed 2022·Granted Aug 12, 2025·0 cites·20 claims
- 2181US2024351982A1Crystalline norpsilocin compoundsCAAMTECH INC·Filed 2024·Application pending·0 cites
- 2280US12497360B2Crystalline 4-hydroxy-N,N-di-n-propyltryptammonium (4-HO-DPT) saltsCAAMTECH INC·Filed 2024·Granted Dec 16, 2025·0 cites·9 claims
- 2380US12343328B2Dialkyl tryptamines and their therapeutic usesCAAMTECH INC·Filed 2021·Granted Jul 1, 2025·0 cites·2 claims
- 2480US12077499B2Crystalline bis-miprocin fumarateCAAMTECH INC·Filed 2023·Granted Sep 3, 2024·0 cites·21 claims
- 2580US11884625B2Crystalline forms of psilacetinCAAMTECH INC·Filed 2022·Granted Jan 30, 2024·0 cites·10 claims
- 2680US2025145569A1Crystalline bufotenidine compoundsCAAMTECH INC·Filed 2024·Application pending·0 cites
- 2779US2023404975A1Compositions comprising a serotonergic tryptamine compoundCAAMTECH INC·Filed 2023·Application pending·0 cites
- 2878US12410129B2Crystalline 5-methoxy-N,N-diallyltryptamine compoundsCAAMTECH INC·Filed 2023·Granted Sep 9, 2025·0 cites·19 claims
- 2978US12404238B2Psilocybin derivativesCAAMTECH INC·Filed 2022·Granted Sep 2, 2025·0 cites·8 claims
- 3078US12162835B2Crystalline psilacetin derivativesCAAMTECH INC·Filed 2023·Granted Dec 10, 2024·0 cites·17 claims
- 3178US11981637B24-pivaloyloxy-n-methyltryptammonium chlorideCAAMTECH INC·Filed 2022·Granted May 14, 2024·0 cites·18 claims
- 3278US2025129024A1Crystalline psilacetin derivativesCAAMTECH INC·Filed 2024·Application pending·0 cites
- 3378US2024383848A1Quaternary tryptamines and their therapeutic usesCAAMTECH INC·Filed 2024·Application pending·0 cites
- 3477US2025051280A1Crystalline bis-miprocin fumarateCAAMTECH INC·Filed 2024·Application pending·0 cites
- 3575US12180157B2Crystalline bufotenidine compoundsCAAMTECH INC·Filed 2022·Granted Dec 31, 2024·0 cites·4 claims
- 3675US2024116867A1Alkyl quaternary ammonium tryptamines and their therapeutic usesCAAMTECH INC·Filed 2023·Application pending·0 cites
- 3775US2024158349A1Tryptamine derivatives and their therapeutic usesCAAMTECH INC·Filed 2023·Application pending·0 cites
- 3874US12414936B2Compositions comprising a serotonergic tryptamine compoundCAAMTECH INC·Filed 2021·Granted Sep 16, 2025·0 cites·3 claims
- 3974US12391645B2N-isopropyl tryptamines and method of making monoalkylated and dialkylated tryptamine analogsCAAMTECH INC·Filed 2023·Granted Aug 19, 2025·0 cites·2 claims
- 4074US12017991B2Quaternary tryptamines and their therapeutic usesCAAMTECH INC·Filed 2022·Granted Jun 25, 2024·0 cites·15 claims
- 4174US2023355701A1Compositions containing kratom compoundsCAAMTECH INC·Filed 2023·Application pending·0 cites
- 4273US2025361206A14-pivaloyloxy-n-methyltryptammonium chlorideCAAMTECH INC·Filed 2023·Application pending·0 cites
- 4373US2023331671A1Crystalline dimethyl tryptamine analoguesCAAMTECH INC·Filed 2023·Application pending·0 cites
- 4472US12134598B2Crystalline 5-methoxy-dipropyl tryptamine compoundsCAAMTECH INC·Filed 2022·Granted Nov 5, 2024·0 cites·18 claims
- 4570US2025162991A1Crystalline 5-methoxy-dipropyl tryptamine compoundsCAAMTECH INC·Filed 2024·Application pending·0 cites
- 4667US9301909B2Compositions and methods for mitigating adverse effects of exposure to oxidizers, such as chlorinating and/or brominating agentsCHADEAYNE ANDREW R·Filed 2012·Granted Apr 5, 2016·1 cites·6 claims
- 4766US2025257033A1Methyl substituted quaternary tryptamine derivativesCAAMTECH INC·Filed 2023·Application pending·0 cites
- 4866US2023406824A1Tryptamine derivatives and their therapeutic usesCAAMTECH INC·Filed 2021·Application pending·0 cites
- 4966US2025263371A1Crystalline 4-(ethylsulfonyloxy)-n,n-di-n-propyltryptammonium chlorideCAAMTECH INC·Filed 2023·Application pending·0 cites
- 5066US2022112162A1Alkyl quaternary ammonium tryptamines and their therapeutic usesCAAMTECH INC·Filed 2021·Application pending·0 cites
Showing the top 50 of 69 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Andrew R. Chadeayne files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →